WINTER CE + SKI MEETING

CE & Ski2013

Montana Pharmacy Association

2013 Montana Pharmacy Association Winter CE & Ski Meeting JANUARY 11–13 • BIG SKY, MONTANA

LOCATION AND RESERVATIONSBig Sky Resort, Big Sky, MontanaFor reservations call: 406.995.5750 or 800.548.4486 Reserve by 12.11.12 and say you are with the MPA conference to receive the block rate. No room cancellations after December 11, 2012.

MEETING INFONorine Rice – MPAPO Box 1569, Helena, MT 59624nrice@montana.com

CE INFOProgram Assistant, ACPE ProgrammingSkaggs School of Pharmacy at the University of Montanapharmacy.ce@umontana.edu (406) 243-4621

Skaggs School of Pharmacy at The University of Montana is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program is targeted to pharmacists. Activities listed in this announcement have been approved for ACPE continuing education credit as indicated. Individual activity descriptions include the amount of credit offered and the Universal Activity Numbers. Statements of credit will be submitted to CPE Monitor within three weeks, upon successful completion of the verification

of continuing education signature sheet and program evaluation form.

JANUARY 11–13, 2013 BIG SKY, MONTANAPROGRAM OVERVIEWThe 2013 Winter Continuing Education Conference, held in beautiful Big Sky, will offer a total of 15 CE hours for pharmacists and technicians attending all 3 meeting days. The program sessions will include topics relevant to various pharmacy practice settings including hospital, ambulatory care, and community. Clinical experts will speak on topics including diabetes, hypercholesterolemia, geriatrics, and pediatrics. Additionally, updates on National Pharmacy initiatives and policy, patient-centered medical home model, and medication errors will be discussed. The conference will conclude with a review of state and national issues affecting the profession of Pharmacy.

Enjoy skiing at the world-renowned Big Sky Resort or take advantage of the many other local activities while sharpening practice skills, enhancing business strategies, networking, and connecting with friends.

Each year generous participants sponsor students and technicians to attend this educational and networking opportunity. To provide a donation for others to participate in the Winter CE meeting, please indicate your preference on the registration form.

1. Discuss the increasing role that the federal government is playing in healthcare and the consequences for community

pharmacy.

2. Provide a general description of the proposed First Databank/Medispan Settlement and its impact on the reporting of

AWP.

3. Identify important legislation relating to the Medicare Part D program for 2007.

4. Describe the role of the Coalition for Community Pharmacy Action formed by the National Community Pharmacists

Association (NCPA) and the National Association of Chain Drug Stores, and the commission of the Grant Thornton

study.

Skaggs School of Pharmacy at the University of Montana is accredited by the Accreditation Council for PharmacyEducation as a provider of continuing pharmacy education. Programs listed in this booklet have been approved forACPE continuing education credit as indicated. Individual program descriptions include the amount of creditoffered and the universal program number. Statements of Credit will be mailed to participants within 4 weeks,upon successful completion of the verification of continuing education signature sheet and program evaluationform. No partial credit.

Presented in collaboration with:

Skaggs School of Pharmacy

Montana Pharmacy AssociationWinter CE/Ski/Swim Conference

January 25 - 27, 2008Fairmont Hot Springs Resort/Discovery Basin Ski Area

Pharmacists may Earn 0.7 CEUsThe goal of this conference is to provide community and health system pharmacists

with current practice information that can be applied across practice

boundries.

Program Overview

FRIDAY, JANUARY 25, 2008

!

The 2008 Winter Continuing Education Conference will in-

clude 7 hours of continuing education addressing several im-

portant topics of current interest to practicing pharmacists.

Participants will learn about current clinical and drug therapy

issues in heart failure and diabetes, as well as relevant legis-

lative and regulatory issues affecting the profesion.

MONTANA PHARMACY ASSOCIATION: Legislative and Regulatory Review, 2008.Mark Kinney, R.Ph., Independent Pharmacy Cooperative

Learning Objectives for pharmacists and pharmacy technicians in a variety of practice settings: After participating in the following

program the participant should be able to:

Pharmacy technicians can fulfill their law requirement at this

conference. In addition, a special continuing education for

pharmacy technicians working with their pharmacists to pro-

vide immunizations is being presented.

There’s an opportunity to sponsor a pharmacy technician or a

student on the registration form.

Enjoy skiing at Discovery Basin or the Mt. Haggin Nordic

Area and soaking in the hot pools while learning, networking

and reconnecting with your peers. Attend this educational

and informational program to become better informed, more

knowledgeable of current practice issues, and better able to

serve your patients and health care community.

FACULTYMARCIE BOUGH, PHARMD, Senior Director, Gov. Affairs, APhA, Washington, DC

CHRISTOPHER SORLI, MD, FACE, Chair, Dept. of Diabetes, Billings Clinic, Billings, MT

JILL PULASKI, RD, CDE, Barrett Hospital and HealthCare, Dillon, MT

IDA REIGHARD, RN, CDE, St. James Hospital, Butte, MT

ANTONETTE DARLINGTON, PHARMD, BCPS, Clinical Pharmacist, Benefis Health System, Great Falls, MT

KERRY HANEY, PHARMD, BCACP, CPP, Assistant Professor, UM Skaggs School of Pharmacy, Missoula, MT

CARLA COX, PHD, RD, CDE, Western MT Clinic and St. Patrick Hospital, Missoula, MT

KIMBERLY VAN WYK, PHARMD, BCPS, Mountain Pacific Quality Health, Helena, MT

CARLA COBB, PHARMD, BCPP, Psychiatric Pharmacist, RiverStone Health, Billings, MT

JASON NICKISCH, PHARMD, BCPS, Women’s & Children’s Pharmacist, Benefis Health System, Great Falls, MT

CRISTINA DUVALL, BA, MS, PHARMD, HSB Pharmacy, Washington State Penitentiary, Dept. of Corrections, Walla Walla, WA

MARK MEREDITH, PHARMD, Chair MPA, BC/BS, Helena, MT

TONY KING, PHARMD, Chair MPA Legislative/Policy Committee, Walgreens, Missoula, MT

STUART DOGGETT, Executive Director, MPA, Helena, MT NEW REQUIREMENT FOR CE PARTICIPANTS CPE MONITOR: DO YOU HAVE YOUR NABP EPROFILE ID NUMBER?Have you set up your NABP e-Profile and registered for the CPE MonitorTM service to ensure your ACPE- accredited CPE units are properly tracked for licensure? Visit MyCPEmonitor.net and create a profile. https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp

WHAT IS CPE MONITOR?A national collaborative effort between the National Association of Boards of Pharmacy® (NABP®), the Accreditation Council for Pharmacy Education (ACPE), and accredited continuing pharmacy education (CPE) providers, the CPE Monitor service will allow you to easily track your ACPE- accredited CPE units electronically.

Many ACPE-accredited CPE providers are now requiring pharmacists and technicians to submit their NABP e-Profile ID, plus their date of birth (MMDD), to receive credit for completed CPE. Participation data will be sent electronically from the provider to ACPE, then to NABP for recording into the matching e-Profile. To ensure that CPE data is accurately recorded and matched to the correct e-Profile, it is important that licensees provide the correct e-Profile ID and date of birth to the CPE provider.

UAN 0035-9999-13-006-L01-P; 0.15 CEUS

4:00–5:20 P.M. Nutrition, Exercise and Diabetes: Education and Applications The Amphitheatre in Huntley Lodge Carla Cox, PhD, RD,CDE Western MT Clinic and St. Patrick Hospital

5:20–5:30 P.M. Questions, Post Test, Evaluation

UAN 0035-9999-13-007-L04-P; 0.15 CEUS

5:30–6:50 P.M. What’s Brewing with the Updated AGS Beers Criteria The Amphitheatre in Huntley Lodge Kimberly Van Wyk, PharmD, BCPS, Mountain Pacific Quality Health

6:50–7:00 P.M. Questions, Post Test, Evaluation

7:00–7:30 P.M. Social Hour Talus Room in the Summit

7:30 P.M. Dinner and Entertainment by “Tumbledown House” Talus Room in the Summit

SUNDAY, JANUARY 13, 2013

7:30 A.M. Breakfast Talus Room in the Summit

UAN 0035-9999-13-008-L04-P; 0.2 CEUS

8:00–9:55 A.M. Comprehensive Medication Management: The Role of the Pharmacist in the Patient-Centered Medical Home The Amphitheatre in Huntley Lodge Carla Cobb, PharmD, BCPP, RiverStone Health

9:55–10:00 A.M. Questions, Post Test, Evaluation

CONCURRENT SESSIONS

UAN 0035-9999-13-009-L04-P; 0.2 CEUS

8:00–9:55 A.M. Pediatrics: Talus Room in the Summit Part I – Cystic Fibrosis Part II – Neonatal Parenteral Nutrition Jason Nickisch, PharmD, BCPS, Women’s & Children’s Pharmacist, Benefis Health System

9:55–10:00 A.M. Questions, Post Test, Evaluation

10:00–10:15 A.M. Break Talus Room in the Summit

UAN 0035-9999-13-010-L05-P; 0.1 CEUS

10:15–11:00 A.M. ISMP: Medication Safety Talus Room in the Summit Cristina DuVall, BA, MS, PharmD, HSB Pharmacy, Washington State Penitentiary, Dept. of Corrections

11:00–11:15 A.M. Questions, Post Test, Evaluation

UAN 0035-9999-13-011-L03-P; 0.2 CEUS

11:15–1:00 P.M. Current Law and Practice Issues in the State & Nation Talus Room in the Summit Mark Meredith, PharmD, Chair MPA, BC/BS, Helena, MT; Tony King, PharmD, Chair MPA Legislative/Policy Committee, Walgreens, Missoula; Stuart Doggett, Executive Director, MPA, Helena, MT

1:00–1:15 P.M. Questions, Post Test, Evaluation

1:15–1:30 P.M. Conference Evaluation

LEGISLATIVE AND REGULATORY UPDATE: DC PERSPECTIVEMarcie Bough, PharmD, Senior Director, Gov. Affairs, APhA

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Describe new federal laws and regulations that will impact pharmacists.

2. Discuss federal legislative and regulatory proposals being considered that could affect pharmacy practice.

3. Discuss various initiatives and projects recognizing the value of pharmacists’ services.

TREATMENT STRATEGIES FOR DIABETES AND OBESITY: UPDATE 2013Dr. Christopher Sorli, MD, FACE, Chair, Dept. of Diabetes, Endocrinology and Metabolism, Billings Clinic

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Diabetes and Obesity: Describe the underlying physiology and complexity of both glucose and whole body energy homeostasis.

2. Diabetes care: Discuss how the new treatment guidelines for diabetes were established and what they mean for evolving pathophysiologic based treatment strategies.

3. Obesity care: Describe novel treatments with drugs and peptide therapeutics.

4. Discuss metabolic surgery and its role in treatment of obesity.

DIABETES: INSULIN, GLUCOSE MONITORS, PUMPS AND MOREJill Pulaski, RD, CDE, Barrett Hopsital and HealthCare and Ida Reighard, RN,CDE,St. James Hopsital

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Identify the different insulin forms available on the market today including the split mixed, premixed, basal-bolus and pump regimens.

2. Review the different administration options.

3. Review and test several different glucose meters.

4. List 4 different insulin pump models and identify appropriate candidates for pump therapy.

HYPERGLYCEMIA IN THE ACUTE CARE SETTINGAntonette Darlington, PharmD, BCPS, Benefis Health System

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Discuss the consequences of acute hyperglycemia in acute care patients.

2. List current glycemic targets in the acute care patient.

3. Describe the treatment of hyperglycemia in the acute care setting.

NCEP ATP IV GUIDELINE UPDATE: WHAT’S NEW IN 2013?Kerry Haney, PharmD, BCACP, CPP, UM Skaggs School of Pharmacy

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. List three anticipated changes to the ATP IV consensus guidelines.

2. Compare and contrast two validated risk assessment tools used to stratify risk of developing cardiovascular disease and individualize LDL-c goals.

3. Describe the primary treatment targets from the draft ATP IV guidelines.

NUTRITION, EXERCISE AND DIABETES: EDUCATION AND APPLICATIONS Carla Cox, PhD, RD, CDE, Western MT Clinic and St. Patrick Hospital

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Describe the latest evidence based nutrition recommendations for prevention and treatment of type 2 diabetes.

2. Differentiate nutrition recommendations for type 1 and type 2 diabetes and the rationale for each.

3. Discuss the recommendations for exercise for individuals with type 1 and type 2 diabetes and potential barriers to patients.

4. List several tips for being a mentor of change for the patient.

WHAT’S BREWING WITH THE UPDATED AGS BEERS CRITERIAKimberly Van Wyk, PharmD, BCPS, Mountain Pacific Quality Health

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Describe the intent, audience, and thoughtful application of the updated Beers criteria including the level of evidence and strength of each recommendation.

2. Review the physiological changes that occur to the human body during the aging process.

3. Recognize potentially inappropriate medications in the elderly, those to be given with caution, and those to avoid with coexisting diseases/syndromes.

4. Compare and contrast the Beers criteria to other published criteria for identifying potentially inappropriate medication use in older adults.

COMPREHENSIVE MEDICATION MANAGEMENT: THE ROLE OF THE PHARMACIST IN THE PATIENT-CENTERED MEDICAL HOMECarla Cobb, PharmD, BCPP, RiverStone Health

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Define terminology used in pharmacy practice including pharmaceutical care, patient-centered medical home, MTM, and comprehensive medication management.

2. Describe the steps necessary to perform comprehensive medication management.

3. Delineate a model practice for a pharmacist working in a patient-centered medical home.

4. Justify the value of pharmacist services to an administrator or payor.

5. Demonstrate the responsibility of the individual pharmacist in achieving payment for pharmacists services.

PEDIATRICS: PART 1: CYSTIC FIBROSIS PART 2: NEONATAL PARENTERAL NUTRITIONJason Nickisch, PharmD, BCPS, Women’s & Children’s Pharmacist, Benefis Health System

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

Cystic Fibrosis objectives:

1. Describe the pathophysiology of cystic fibrosis, organ systems involved, and the prognosis.

2. Discuss targeted treatments to specific organ systems.

3. List differences in pharmacokinetic parameters in this patient population.

Neonatal Parenteral Nutrition objectives:

1. Describe fluid and caloric requirements in the neonatal population.

2. Describe the importance of starter parenteral nutrition.

3. Discuss monitoring parameters for parenteral nutrition.

ISMP: MEDICATION SAFETYCristina DuVall, BA, MS, PharmD, HSB Pharmacy, Washington State Penitentiary, Dept. of Corrections

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. Define ISMP’s role in promoting medication safety.

2. Identify examples of medication errors that should be reported.

3. Describe how to report to the Montana Board of Pharmacy and/or ISMP.

CURRENT LAW AND PRACTICE ISSUES IN THE STATE & NATIONMark Meredith, PharmD, Chair MPA, BC/BS; Tony King, PharmD, Chair MPA Legislative/Policy Committee, Walgreens; Stuart Doggett, Executive Director, MPA

OBJECTIVES: At the conclusion of the presentation, participants should be able to:

1. List two legislative initiatives that MPA is seeking to pass during the 2013 legislature.

2. Identify one recent change to Administrative Rule passed by the Montana Board of Pharmacy.

3. Identify one primary federal initiative being worked on by national pharmacy representatives.

GOALS & OBJECTIVES AGENDA

FRIDAY, JANUARY 11, 20139:00 A.M. Board of Pharmacy Meeting

2:00 P.M. MPA Board Meeting Summit Boardroom

9:15 A.M.-4:00 P.M. Ski or Recreational Activities

3:00-4:00 P.M. Vendor Set-Up Talus Room in the Summit and Registration Summit Upper Lobby

5:30-6:30 P.M. Social Hour and Visit your vendor Talus Room in the Summit

6:30-7:30 P.M. Dinner Talus Room in the Summit

UAN 0035-9999-13-001-L03-P; 0.2 CEUS

7:00–8:45 P.M. Legislative and Regulatory Update: DC Perspective Marcie Bough, PharmD, Senior Director, Gov. Affairs, APhA

8:45–9:00 P.M. Questions, Post Test, Evaluation

SATURDAY, JANUARY 12, 20136:30 A.M. Breakfast in Vendor area Talus Room in the Summit

8:00 A.M. Skiers leave (full day) or Recreational Activities

UAN 0035-9999-13-002-L01-P; 0.2 CEUS

7:00–8:45 A.M. Treatment Strategies for Diabetes and Obesity: Update 2013 The Amphitheatre in Huntley Lodge Dr. Christopher Sorli, MD, FACE, Chair, Department of Diabetes, Endocrinology and Metabolism, Billings Clinic

8:45–9:00 A.M. Questions, Post Test, Evaluation

9:45–10:00 A.M. Break Talus Room in the Summit

UAN 0035-9999-13-003-L01-P; 0.1 CEUS

9:15–10:00 A.M. Diabetes: Insulin, Glucose Monitors, Pumps and More The Amphitheatre in Huntley Lodge Jill Pulaski, RD, CDE, Barrett Hospital and HealthCare and Ida Reighard, RN,CDE, St. James Hospital

10:00–10:15 A.M. Questions, Post Test, Evaluation

UAN 0035-9999-13-004-L01-P; 0.1 CEUS

10:15–11:00 A.M. Hyperglycemia in the Acute Care Setting The Amphitheatre in Huntley Lodge Antonette Darlington, PharmD, BCPS, Benefis Heath System

11:00–11:15 A.M. Questions, Post Test, Evaluation

UAN 0035-9999-13-005-L01-P; 0.1 CEUS

11:15–12:00 A.M. NCEP ATP IV Guideline Update: What’s New in 2013? The Amphitheatre in Huntley Lodge Kerry Haney, PharmD, BCACP, CPP, UM Skaggs School of Pharmacy

12:00–12:15 p.m. Questions, Post Test, Evaluation

12:15 P.M. Lunch Talus Room in the Summit

1:00 P.M. Skiers Leave (1/2 day) or Recreational Activities

1:00 P.M. Vendors break down